Population attributable fractions of fatty liver disease for type 2 diabetes Mellitus

被引:1
|
作者
Xu, Jingyuan [1 ,2 ]
Wu, Longyun [3 ]
Deng, Jiang [1 ]
Yang, Longbao [1 ]
Wang, Yatao [1 ]
Tian, Hongyang [3 ]
Ji, Yajun [3 ]
Xia, Qiaoyun [3 ]
Han, Zhiyi [4 ]
Cheng, Yan [1 ]
Lu, Xiaolan [1 ,3 ]
机构
[1] Xi An Jiao Tong Univ, Dept Gastroenterol, Affiliated Hosp 2, Xian 710004, Peoples R China
[2] Nanjing Med Univ, Dept Gastroenterol, Affiliated Suzhou Hosp, 16 Baita West Rd, Suzhou 215001, Peoples R China
[3] Fudan Univ, Dept Gastroenterol, Shanghai Pudong Hosp, Shanghai 201399, Peoples R China
[4] Karamay Cent Hosp Xinjiang, Karamay 834099, Peoples R China
关键词
Fatty liver disease; Type 2 diabetes mellitus; Population attributable fraction; Cohort studies; Metabolic diseases; METABOLIC SYNDROME; RISK; ASSOCIATION; MANAGEMENT; DIAGNOSIS; SEX;
D O I
10.1186/s12902-023-01433-z
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
PurposeTo determine the population attributable fraction (PAF) of fatty liver disease (FLD) for type 2 diabetes mellitus (T2DM) and compare it to the PAFs of other metabolic abnormalities.MethodsWe conducted a 10-year retrospective cohort study of 33,346 individuals in Karamay Central Hospital of Xinjiang. Individuals were followed up for T2DM occurrence based on FBS. The PAFs of FLD were calculated generally and respectively in different sex and age groups. A comparison of the PAF of FLD and that of other metabolic abnormalities, as well as the PAFs of FLD in different groups classified based on age and sex, was performed using Cox regression.ResultsDuring an average follow-up period of 3.71 years, 1486 T2DM were diagnosed. The incidence density of T2DM was 1.2/100 person-years, and cumulative incidence rate was 4456.31/100,000 person-years. Partial PAF (PAFp) of FLD in the entire population was 23.11%. In the male population, PAFp was higher at 30-40 years old. In the female population, it was higher when age & GE; 60 years old. In multivariable Cox regression model, FLD, male sex, age & GE; 45 years old, overweight, hypertriglyceridaemia, and systolic hypertension were independent risk factors for T2DM, with corresponding PAFp of 25.00%, 24.99%, 36.47%, 24.96%, 5.71%, and 6.76%, respectively. Age & GE; 45 years old showed the highest PAFp and adjusted hazard ratio, followed by FLD.ConclusionsFLD contributes more to T2DM incidence than other metabolic disorders. Particular attention should be given to male populations of 30-40 and female populations above 60 for FLD prevention and treatment.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] Population attributable fractions of fatty liver disease for type 2 diabetes Mellitus
    Jingyuan Xu
    Longyun Wu
    Jiang Deng
    Longbao Yang
    Yatao Wang
    Hongyang Tian
    Yajun Ji
    Qiaoyun Xia
    Zhiyi Han
    Yan Cheng
    Xiaolan Lu
    BMC Endocrine Disorders, 23
  • [2] Nonalcoholic fatty liver disease in type 2 diabetes mellitus
    Cusi, Kenneth
    CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY, 2009, 16 (02) : 141 - 149
  • [3] Fatty liver disease diagnosis in type 2 diabetes mellitus
    Grander, C.
    Tilg, H.
    DIABETOLOGE, 2016, 12 (07): : 473 - 477
  • [4] Role of type 2 diabetes mellitus in nonalcoholic fatty liver disease
    Filik, L.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2011, 41 (12) : 1367 - 1367
  • [5] The Coexistence of Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus
    Kosmalski, Marcin
    Ziolkowska, Sylwia
    Czarny, Piotr
    Szemraj, Janusz
    Pietras, Tadeusz
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (05)
  • [6] The effect of liraglutide on nonalcoholic fatty liver disease in type 2 diabetes mellitus
    Xueyang Zhang
    Ran Bai
    Yong Jia
    Junwei Zong
    Yongbo Wang
    Yanan Dong
    International Journal of Diabetes in Developing Countries, 2020, 40 : 491 - 499
  • [7] Nonalcoholic Fatty Liver Disease The New Complication of Type 2 Diabetes Mellitus
    Bril, Fernando
    Cusi, Kenneth
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2016, 45 (04) : 765 - +
  • [8] Mechanism of TangGanJian on nonalcoholic fatty liver disease with type 2 diabetes mellitus
    Fan, Yanbo
    Xiong, Wei
    Li, Jingjing
    Hu, Aimin
    He, Zhiwei
    Zhang, Jiawen
    Zhou, Guoyun
    Yin, Qiang
    PHARMACEUTICAL BIOLOGY, 2018, 56 (01) : 567 - 572
  • [9] Non-alcoholic fatty liver disease and type 2 diabetes mellitus
    Par Alajos
    Wittmann Istvan
    Par Gabriella
    ORVOSI HETILAP, 2022, 163 (22) : 855 - 862
  • [10] Non-alcoholic fatty liver disease and type 2 diabetes mellitus
    Par Alajos
    Wittmann Istvan
    Par Gabriella
    ORVOSI HETILAP, 2022, 163 (21) : 815 - 825